BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 29626121)

  • 1. Reproducibility and Repeatability of Semiquantitative
    Vargas HA; Kramer GM; Scott AM; Weickhardt A; Meier AA; Parada N; Beattie BJ; Humm JL; Staton KD; Zanzonico PB; Lyashchenko SK; Lewis JS; Yaqub M; Sosa RE; van den Eertwegh AJ; Davis ID; Ackermann U; Pathmaraj K; Schuit RC; Windhorst AD; Chua S; Weber WA; Larson SM; Scher HI; Lammertsma AA; Hoekstra OS; Morris MJ
    J Nucl Med; 2018 Oct; 59(10):1516-1523. PubMed ID: 29626121
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessment of Simplified Methods for Quantification of
    Kramer GM; Yaqub M; Vargas HA; Schuit RC; Windhorst AD; van den Eertwegh AJM; van der Veldt AAM; Bergman AM; Burnazi EM; Lewis JS; Chua S; Staton KD; Beattie BJ; Humm JL; Davis ID; Weickhardt AJ; Scott AM; Morris MJ; Hoekstra OS; Lammertsma AA
    J Nucl Med; 2019 Sep; 60(9):1221-1227. PubMed ID: 30850488
    [No Abstract]   [Full Text] [Related]  

  • 3. Repeatability of Quantitative 18F-Fluoromethylcholine PET/CT Studies in Prostate Cancer.
    Oprea-Lager DE; Kramer G; van de Ven PM; van den Eertwegh AJ; van Moorselaar RJ; Schober P; Hoekstra OS; Lammertsma AA; Boellaard R
    J Nucl Med; 2016 May; 57(5):721-7. PubMed ID: 26697964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity of
    Cysouw MCF; Kramer GM; Heijtel D; Schuit RC; Morris MJ; van den Eertwegh AJM; Voortman J; Hoekstra OS; Oprea-Lager DE; Boellaard R
    EJNMMI Res; 2019 Jul; 9(1):70. PubMed ID: 31363939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeatability of Quantitative 18F-NaF PET: A Multicenter Study.
    Lin C; Bradshaw T; Perk T; Harmon S; Eickhoff J; Jallow N; Choyke PL; Dahut WL; Larson S; Humm JL; Perlman S; Apolo AB; Morris MJ; Liu G; Jeraj R
    J Nucl Med; 2016 Dec; 57(12):1872-1879. PubMed ID: 27445292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeatability of Quantitative
    Jansen BHE; Cysouw MCF; Vis AN; van Moorselaar RJA; Voortman J; Bodar YJL; Schober PR; Hendrikse NH; Hoekstra OS; Boellaard R; Oprea-Lager DE
    J Nucl Med; 2020 Sep; 61(9):1320-1325. PubMed ID: 31924729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeatability of quantitative
    Kramer GM; Liu Y; de Langen AJ; Jansma EP; Trigonis I; Asselin MC; Jackson A; Kenny L; Aboagye EO; Hoekstra OS; Boellaard R;
    Eur J Nucl Med Mol Imaging; 2018 Jun; 45(6):951-961. PubMed ID: 29362858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High SUVs Have More Robust Repeatability in Patients with Metastatic Prostate Cancer: Results from a Prospective Test-Retest Cohort Imaged with
    Werner RA; Habacha B; Lütje S; Bundschuh L; Higuchi T; Hartrampf P; Serfling SE; Derlin T; Lapa C; Buck AK; Essler M; Pienta KJ; Eisenberger MA; Markowski MC; Shinehouse L; AbdAllah R; Salavati A; Lodge MA; Pomper MG; Gorin MA; Bundschuh RA; Rowe SP
    Mol Imaging; 2022; 2022():7056983. PubMed ID: 35283693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Healthy Tissue Uptake of
    Jansen BHE; Kramer GM; Cysouw MCF; Yaqub MM; de Keizer B; Lavalaye J; Booij J; Vargas HA; Morris MJ; Vis AN; van Moorselaar RJA; Hoekstra OS; Boellaard R; Oprea-Lager DE
    J Nucl Med; 2019 Aug; 60(8):1111-1117. PubMed ID: 30630941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron Emission Tomography/Computed Tomography-Based Assessments of Androgen Receptor Expression and Glycolytic Activity as a Prognostic Biomarker for Metastatic Castration-Resistant Prostate Cancer.
    Fox JJ; Gavane SC; Blanc-Autran E; Nehmeh S; Gönen M; Beattie B; Vargas HA; Schöder H; Humm JL; Fine SW; Lewis JS; Solomon SB; Osborne JR; Veach D; Sawyers CL; Weber WA; Scher HI; Morris MJ; Larson SM
    JAMA Oncol; 2018 Feb; 4(2):217-224. PubMed ID: 29121144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeatability of Quantitative Whole-Body 18F-FDG PET/CT Uptake Measures as Function of Uptake Interval and Lesion Selection in Non-Small Cell Lung Cancer Patients.
    Kramer GM; Frings V; Hoetjes N; Hoekstra OS; Smit EF; de Langen AJ; Boellaard R
    J Nucl Med; 2016 Sep; 57(9):1343-9. PubMed ID: 27103020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Test-retest repeatability of quantitative bone SPECT/CT.
    Yamane T; Fukushima K; Shirotake S; Nishimoto K; Okabe T; Oyama M; Seto A; Kuji I
    Ann Nucl Med; 2021 Mar; 35(3):338-346. PubMed ID: 33400148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response-to-repeatability of quantitative imaging features for longitudinal response assessment.
    Lin C; Harmon S; Bradshaw T; Eickhoff J; Perlman S; Liu G; Jeraj R
    Phys Med Biol; 2019 Jan; 64(2):025019. PubMed ID: 30566922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uptake of Radium-223 Dichloride and Early [
    Letellier A; Johnson AC; Kit NH; Savigny JF; Batalla A; Parienti JJ; Aide N
    Mol Imaging Biol; 2018 Jun; 20(3):482-491. PubMed ID: 29027074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeatability of 18F-FDG PET/CT in Advanced Non-Small Cell Lung Cancer: Prospective Assessment in 2 Multicenter Trials.
    Weber WA; Gatsonis CA; Mozley PD; Hanna LG; Shields AF; Aberle DR; Govindan R; Torigian DA; Karp JS; Yu JQ; Subramaniam RM; Halvorsen RA; Siegel BA; ;
    J Nucl Med; 2015 Aug; 56(8):1137-43. PubMed ID: 25908829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone metastases in castration-resistant prostate cancer: associations between morphologic CT patterns, glycolytic activity, and androgen receptor expression on PET and overall survival.
    Vargas HA; Wassberg C; Fox JJ; Wibmer A; Goldman DA; Kuk D; Gonen M; Larson SM; Morris MJ; Scher HI; Hricak H
    Radiology; 2014 Apr; 271(1):220-9. PubMed ID: 24475817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Test-Retest Reproducibility of
    Kurland BF; Peterson LM; Shields AT; Lee JH; Byrd DW; Novakova-Jiresova A; Muzi M; Specht JM; Mankoff DA; Linden HM; Kinahan PE
    J Nucl Med; 2019 May; 60(5):608-614. PubMed ID: 30361381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific
    Larimer BM; Dubois F; Bloch E; Nesti S; Placzek M; Zadra G; Hooker JM; Loda M; Mahmood U
    J Nucl Med; 2018 Oct; 59(10):1538-1543. PubMed ID: 29853654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Test-Retest Repeatability of Patlak Slopes versus Standardized Uptake Values for Hypermetabolic Lesions and Normal Organs in an Oncologic PET/CT Population.
    Ince S; Laforest R; Ashrafinia S; Smith AM; Wahl RL; Fraum TJ
    Mol Imaging Biol; 2024 Apr; 26(2):284-293. PubMed ID: 38466523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.